Although clinical studies have shown a better PARPi response in BRCA2-mutated PCa compared with ATM and CHEK2 alterations,37 Lotan et al53 showed the same correlation with higher HRD scores in the respective HRR gene mutations. The gene discussed is CHEK2; the disease is posterior cortical atrophy.